NDAOPHTHALMICSUSPENSION/DROPS
Approved
Dec 1964
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CORTISPORIN (hydrocortisone; neomycin sulfate; polymyxin b sulfate) by Monarch Therapeutics is clinical pharmacology colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Approved for superficial bacterial infections of the external auditory canal, caused by organisms susceptible to the action of the antibiotics. First approved in 1964.
Drug data last refreshed 16h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORTISPORIN is a fixed-dose combination ophthalmic suspension containing hydrocortisone (corticosteroid), neomycin sulfate, and polymyxin B sulfate (aminoglycoside and polypeptide antibiotics). It treats superficial bacterial infections of the external auditory canal by combining anti-inflammatory action with broad-spectrum bactericidal coverage against gram-positive and gram-negative organisms. The corticosteroid suppresses inflammation while the antibiotics disrupt bacterial cell membranes and protein synthesis.
LOE Approaching
Product approaching loss of exclusivity with minimal competitive pressure (30), suggesting declining team investment and focus on generic transition management rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial cell membrane. Neomycin sulfate is an aminoglycoside antibiotic which inhibits protein synthesis, disrupting the normal cycle of ribosomal function. Hydrocortisone acetate is a…
Worked on CORTISPORIN at Monarch Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.